Showing posts with label Axalta. Show all posts
Showing posts with label Axalta. Show all posts

Saturday, October 29, 2022

Axalta Gaining Share, But Still Seeing Punishing Cost Pressure

My bullish call on Axalta (NYSE:AXTA) back in April of 2021 was the wrong call, as the shares have dropped about 20% since then - slotting in between PPG (PPG) (worse) and Sherwin-Williams (SHW). While my thesis of leveraging recovering volumes wasn't entirely off-base, the reality is that passenger vehicle volumes were hit harder than I expected by semiconductor shortages. On top of that, Axalta saw a punishing level of cost pressure that it couldn't fully offset with price.

I may be a glutton for punishment here, but I still think there's a buy argument for Axalta. The company has been gaining share in most of its major categories (refinish, light vehicle and commercial vehicle), and while there's a long way to go to recoup cost inflation, any meaningful easing of input costs (more likely in a slowing economy) would have a very positive effect on margins. Between low-single-digit revenue growth, high-teens EBITDA margins, and mid single-digit FCF growth, I think Axalta is undervalued now.

 

Click the link to continue reading: 

Axalta Gaining Share, But Still Seeing Punishing Cost Pressure

Tuesday, April 13, 2021

Eventual Post-Pandemic Normalization And Better Margins Can Support A Higher Price For Axalta

 

Axalta’s (AXTA) recovery is probably going to look a little different than most other industrial companies, and certainly other coatings companies. With a large piece of the business leveraged to the auto refinish market, the post-pandemic recovery is likely to be a later in the cycle, driven by a more gradual return to pre-pandemic behaviors. Axalta also lacks meaningful exposure to architectural coatings, a significant driver for many paint companies given the strength in the residential new-build and remodel markets.

I don’t believe a modestly delayed recovery in revenue is a particularly good reason to avoid Axalta. I do also see the possibility for more M&A activity here – with both sides of the story (Axalta as a buyer or seller) in play.

Low single-digit revenue growth and mid-single-digit FCF growth, as well as mid-teens operating margin and low 22%’s EBITDA margin, can support a fair value in the low-to-mid $30’s today, and a long-term annualized return in the mid-to-high single-digits. I would argue that’s good enough to make Axalta worthy of further consideration.

 

Read the full article at Seeking Alpha: 

Eventual Post-Pandemic Normalization And Better Margins Can Support A Higher Price For Axalta